Comparative efficacy and safety of intralesional corticosteroids vs. systemic therapy and surgery for idiopathic granulomatous mastitis: a systematic review and network meta-analysis
Frontiers in Medicine · 16.11.2026 · 13
DOI: 10.3389/fmed.2026.1968226 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Medicine, online erschienen am 16.11.2026. Verfasst von Yuandong Zheng und 1 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
The comparative efficacy and safety of available treatments for idiopathic granulomatous mastitis remain uncertain. We aimed to compare intralesional, oral, and topical steroids, surgery, and their combination therapies on clinical response and adverse events using a network meta-analysis.
Methods
In this systematic review and network meta-analysis (PROSPERO: CRD420261447160), we searched PubMed, Embase, Cochrane Library, Web of Science, CNKI, and Wanfang through June 2026 for randomized controlled trials on idiopathic granulomatous mastitis. Interventions included intralesional, oral, or topical steroids, surgery, and their combination therapies. A frequentist random-effects network meta-analysis was performed. Risk of bias was evaluated using RoB 2, and certainty of evidence was assessed with CINeMA.
Results
Seven randomized controlled trials involving 582 participants across seven intervention nodes were included. For complete clinical response, no intervention was significantly superior to oral steroids, whereas conventional surgery (limited to traditional incision and drainage, and primary suture surgery in the analyzed trials) was associated with a significantly lower complete response rate compared with oral steroids (risk ratio 0.34, 95% confidence interval 0.13–0.89; low certainty). Regarding overall response rate, all comparisons against oral steroids crossed the null effect line, showing no statistically significant differences (low certainty). For safety, intralesional steroid injection significantly reduced adverse events compared with oral steroids (odds ratio 0.30, 95% confidence interval 0.12–0.76; low certainty), ranking highest with a SUCRA of 94.5% (probability of being the safest treatment: 81.8%). Oral steroids combined with intralesional steroid injection (OS + ISI) ranked highest for complete response in SUCRA (91.1%; probability of being the best treatment: 74.2%); however, this ranking should be interpreted with caution given the statistically non-significant difference from oral steroids alone and low certainty of evidence.
Conclusions
Low-certainty evidence suggests intralesional steroid injection may reduce adverse events compared with oral steroids, with no statistically significant difference in complete response, although true equivalence cannot be established. Given sparse trial data, the observed inferiority of surgery applies strictly to upfront conventional procedures and warrants cautious interpretation. Further high-quality trials are warranted. Systematic Review Registration https://www.crd.york.ac.uk/PROSPERO/view/CRD420261447160 , Identifier CRD420261447160.
Zitieren
APA
Zheng, Y., & Li, G. (2026). Comparative efficacy and safety of intralesional corticosteroids vs. systemic therapy and surgery for idiopathic granulomatous mastitis: a systematic review and network meta-analysis. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1968226
Vancouver
Zheng Y, Li G. Comparative efficacy and safety of intralesional corticosteroids vs. systemic therapy and surgery for idiopathic granulomatous mastitis: a systematic review and network meta-analysis. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1968226
BibTeX
@article{Zheng2026,
author = {Zheng, Yuandong and Li, Guoxin},
title = {Comparative efficacy and safety of intralesional corticosteroids vs. systemic therapy and surgery for idiopathic granulomatous mastitis: a systematic review and network meta-analysis},
journal = {Frontiers in Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fmed.2026.1968226}
}
EUVIMED